Cencora, Inc. (LON:0HF3)
London · Delayed Price · Currency is GBP · Price in USD 291.52
+1.28 (0.44%)
At close: Jul 25, 2025
Revenue by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2012 - 2019 |
US Human Health | 259.97B | Log In | Log In | Log In | Log In | Upgrade |
US Human Health Growth | 13.41% | Log In | Log In | Log In | Log In | Upgrade |
US Animal Health | 5.37B | Log In | Log In | Log In | Log In | Upgrade |
US Animal Health Growth | 5.29% | Log In | Log In | Log In | Log In | Upgrade |
Other Healthcare Solutions | 5.57B | Log In | Log In | Log In | Log In | Upgrade |
Other Healthcare Solutions Growth | 5.24% | Log In | Log In | Log In | Log In | Upgrade |
Other | -8.37M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 126.26% | Log In | Log In | Log In | Log In | Upgrade |
International Alliance Healthcare | 23.06B | Log In | Log In | Log In | Log In | Upgrade |
International Alliance Healthcare Growth | 2.39% | Log In | Log In | Log In | Log In | Upgrade |
Other | -8.37M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 126.26% | Log In | Log In | Log In | Log In | Upgrade |
EBIT by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2012 - 2019 |
Other | -608.12M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -7.91% | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Distribution Services Segment Operating Income | - | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Distribution Services Segment Operating Income Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Total Other Segment Operating Income | - | Log In | Log In | Log In | Log In | Upgrade |
Total Other Segment Operating Income Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | -608.12M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -7.91% | Log In | Log In | Log In | Log In | Upgrade |
US Healthcare Solutions Operating Income | 2.93B | Log In | Log In | Log In | Log In | Upgrade |
US Healthcare Solutions Operating Income Growth | 13.86% | Log In | Log In | Log In | Log In | Upgrade |
International Healthcare Solutions Operating Income | 713.38M | Log In | Log In | Log In | Log In | Upgrade |
International Healthcare Solutions Operating Income Growth | -8.31% | Log In | Log In | Log In | Log In | Upgrade |